More from Renaissance Capital
Referenced Stocks

Biotech Radius Health postpones $62 million IPO

By Renaissance Capital,  November 14, 2012, 08:05:54 AM EDT

Radius Health, a biotech developing treatments to restore bone loss from osteoporosis, postponed its IPO on Wednesday, citing poor market conditions. The Cambridge, MA-based company was founded in 2003 and booked no revenue in the 12 months ended 6/30/2012. UBS Investment Bank and Leerink Swann were set to be the joint bookrunners on the deal.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: News Headlines, IPOs

Referenced Stocks: RDUS



Latest News Video

Man, Not Economy, in Crisis, Says Pope
Man, Not Economy, in Crisis, Says P...
Chileans March For Marijuana Legalisation
Chileans March For Marijuana Legali...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into to the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.

From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.43 0.07  0.52%
CSCO $ 24.24 0.35  1.48%
MSFT $ 34.87 0.79  2.32%
F $ 15.08 0.44  3.01%
ARUN $ 13.10 4.51  25.61%
SIRI $ 3.50 0.05  1.45%
GE $ 23.46 0.19  0.82%
S $ 7.32 0.04  0.55%